Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Kraut

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Sarcoma|June 4, 2008
A unique radiation scheme for the treatment of high-grade non-metastatic soft tissue sarcoma: the detroit medical center experienceJames Fontanesi, Michael P Mott, Michael J Kraut, et al.
Sarcoma|June 4, 2008
The role of irradiation in the management of locally recurrent non-metastatic soft tissue sarcoma of extremity/trunkal locationsJames Fontanesi, Michael P Mott, David R Lucas, et al.
Sarcoma|June 4, 2008
The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumorsJames Fontanesi, Michael P Mott, Michael J Kraut, et al.
Clinical Lung Cancer|June 15, 2007
Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancerAntoinette J Wozniak, Kimberly Belzer, Lance K Heilbrun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancerShirish M Gadgeel, Antoinette Wozniak, John C Ruckdeschel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapyBryan J Schneider, Gregory P Kalemkerian, Michael J Kraut, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Clinical Lung Cancer|July 16, 2010
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancerBryan J Schneider, Gregory P Kalemkerian, Nithya Ramnath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)Valerie W Rusch, Dorothy J Giroux, Michael J Kraut, et al.
Investigational New Drugs|February 20, 2009
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancerBryan J Schneider, Francis P Worden, Shirish M Gadgeel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Sarcoma|June 4, 2008
A unique radiation scheme for the treatment of high-grade non-metastatic soft tissue sarcoma: the detroit medical center experienceJames Fontanesi, Michael P Mott, Michael J Kraut, et al.
Sarcoma|June 4, 2008
The role of irradiation in the management of locally recurrent non-metastatic soft tissue sarcoma of extremity/trunkal locationsJames Fontanesi, Michael P Mott, David R Lucas, et al.
Sarcoma|June 4, 2008
The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumorsJames Fontanesi, Michael P Mott, Michael J Kraut, et al.
Clinical Lung Cancer|June 15, 2007
Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancerAntoinette J Wozniak, Kimberly Belzer, Lance K Heilbrun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancerShirish M Gadgeel, Antoinette Wozniak, John C Ruckdeschel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapyBryan J Schneider, Gregory P Kalemkerian, Michael J Kraut, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2007
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Sujith R Kalmadi, Cathryn Rankin, Michael J Kraut, et al.
Clinical Lung Cancer|July 16, 2010
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancerBryan J Schneider, Gregory P Kalemkerian, Nithya Ramnath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)Valerie W Rusch, Dorothy J Giroux, Michael J Kraut, et al.
Investigational New Drugs|February 20, 2009
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancerBryan J Schneider, Francis P Worden, Shirish M Gadgeel, et al.
Pageof 2